The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections
Abstract
Infections caused by drug-resistant pathogens are on the rise. Daptomycin, a cyclic lipopeptide with activity against most Gram-positive pathogens, including vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus, is a newly US-FDA approved antimicrobial for complicated skin and skin structure infections (cSSSI). Daptomycin has a unique mechanism of action that results in destruction of the membrane potential. The rapid bactericidal activity of daptomycin makes it an attractive antibiotic for serious Gram-positive infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arbeit, R. D., Maki, D., Tally, F. P., Campanaro, E., Eisenstein, B. I., & Daptomycin 98-01 and 99-01 Investigators (2004) · Clinical Infectious Diseases · doi:10.1086/420818 · Cited by 689
Self-citationCorrelation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureus
Silverman, J. A., Perlmutter, N. G., & Shapiro, H. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2538-2544.2003 · Cited by 656
Cell Wall Thickening Is a Common Feature of Vancomycin Resistance in Staphylococcus aureus
Cui, L., Ma, X., Sato, K., Okuma, K., Tenover, F. C., Mamizuka, E. M., Gemmell, C. G., Kim, M.-N., Ploy, M.-C., El Solh, N., et al. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.1.5-14.2003 · Cited by 492
In Vivo Pharmacodynamic Activity of Daptomycin
Safdar, N., Andes, D., & Craig, W. A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.63-68.2004 · Cited by 370
Rybak, M. J., Hershberger, E., Moldovan, T., & Grucz, R. G. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.1062-1066.2000 · Cited by 362
Fluit, A. C., Wielders, C. L. C., Verhoef, J., & Schmitz, F.-J. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.10.3727-3732.2001 · Cited by 287
Epidemiology of methicillin-resistant staphylococci in Europe
Stefani, S., & Varaldo, P. E. (2003) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2003.00698.x · Cited by 253
Resistance Studies with Daptomycin
Silverman, J. A., Oliver, N., Andrew, T., & Li, T. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1799-1802.2001 · Cited by 234
Once-Daily Dosing in Dogs Optimizes Daptomycin Safety
Oleson, F. B., Berman, C. L., Kirkpatrick, J. B., Regan, K. S., Lai, J.-J., & Tally, F. P. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.2948-2953.2000 · Cited by 196
Self-citationSakoulas, G., Eliopoulos, G. M., Moellering, Jr., Novick, R. P., Venkataraman, L., Wennersten, C., DeGirolami, P. C., Schwaber, M. J., & Gold, H. S. (2003) · The Journal of Infectious Diseases · doi:10.1086/368128 · Cited by 187
Pharmacodynamics of Daptomycin in a Murine Thigh Model of Staphylococcus aureus Infection
Louie, A., Kaw, P., Liu, W., Jumbe, N., Miller, M. H., & Drusano, G. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.845-851.2001 · Cited by 172
Petersen, P. J., Bradford, P. A., Weiss, W. J., Murphy, T. M., Sum, P. E., & Projan, S. J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2595-2601.2002 · Cited by 169
Bell, J. M., & Turnidge, J. D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.880-882.2002 · Cited by 165
Barry, A. L., FUCHS, P. C., & Brown, S. D. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1919-1922.2001 · Cited by 158
Canepari, P., Boaretti, M., Lleò, M. M., et al. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1220 · Cited by 148
Daptomycin activity and spectrum: a worldwide sample of 6737 clinical Gram-positive organisms
Streit, J. M. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh143 · Cited by 148
Dandekar, P. K., Tessier, P. R., Williams, P., Nightingale, C. H., & Nicolau, D. P. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg337 · Cited by 119
Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci
Rand, K. H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh104 · Cited by 114
Critchley, I. A. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg130 · Cited by 113
Cottagnoud, P., Pfister, M., Acosta, F., Cottagnoud, M., Flatz, L., Kühn, F., Müller, H.-P., & Stucki, A. N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3928-3933.2004 · Cited by 109
Snydman, D. R., Jacobus, N. V., McDermott, L. A., Lonks, J. R., & Boyce, J. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3447-3450.2000 · Cited by 101
Pharmacokinetics and Inflammatory Fluid Penetration of Intravenous Daptomycin in Volunteers
Wise, R. A., Gee, T., Andrews, J. M., Dvorchik, B. H., & Marshall, G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.31-33.2002 · Cited by 97
Daptomycin Dose-Effect Relationship against Resistant Gram-Positive Organisms
Cha, R., Grucz, R. G., & Rybak, M. J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1598-1603.2003 · Cited by 95
Kaatz, G. W., Seo, S. M., Reddy, V. N., et al. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.11.2081 · Cited by 61
The in vitro activity of daptomycin against Staphylococcus aureus and Enterococcus species
Richter, S. S., Kealey, D. E., Murray, C. T., Heilmann, K. P., Coffman, S. L., & Doern, G. V. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg288 · Cited by 59
Vaudaux, P. E. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg277 · Cited by 48
Cha, R., & Rybak, M. J. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh259 · Cited by 47
Verdier, I., Reverdy, M. E., Étienne, J., Lina, G., Bes, M., & Vandenesch, F. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.1024-1027.2004 · Cited by 40
Vancomycin-induced deletion of the methicillin resistance gene mecA in Staphylococcus aureus
Adhikari, R. P. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh350 · Cited by 39
Daptomycin in vitro susceptibility in European Gram-positive clinical isolates
Fluit, A. C., Schmitz, F. J., Verhoef, J., & Milatović, D. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.12.014 · Cited by 33
Alder, J. D., Li, T., Yu, D., Morton, L., Silverman, J. A., Zhang, X.-X., Critchley, I. A., & Thorne, G. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3561-3566.2003 · Cited by 31
Self-citation
Cited by
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
Zavascki, A. P., Goldani, L. Z., Li, J., & Nation, R. L. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm357 · Cited by 834
Mechanisms of antibiotic resistance in enterococci
Miller, W. R., Munita, J. M., & Arias, C. A. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.956092 · Cited by 772
Ultrashort antibacterial and antifungal lipopeptides
Makovitzki, A., Avrahami, D., & Shai, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606129103 · Cited by 468
Straus, S. K., & Hancock, R. E. W. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.02.009 · Cited by 446
Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin
French, G. L. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl393 · Cited by 441
Metadata
- Authors
- Steenbergen, J. N., Alder, J., Thorne, G. M., & Tally, F. P.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-03-01
- Volume
- 55
- Issue
- 3
- Pages
- 283-288
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2096763392
- Cited by
- 561
- References
- 31
- FWCI
- 16.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.